In both its targeted therapeutic areas and primary care, Ipsen has a diversified portfolio of leading drugs.
The Group's product portfolio includes pharmaceutical products marketed around the world to specialists working in its targeted therapeutic areas (neurology, endocrinology, uro-oncology, hematology), which are its primary areas of development. The Group also markets products in other therapeutic areas in which it boasts longstanding expertise (gastroenterology, cardiovascular and cognitive disorders). To a large extent, these are composed of primary care.
|Dysport||Somatuline®||Décapeptyl®||Nisis® - Nisisco®|
|Somatuline® - Autogel®||Hexvix®||Forlax®|